Correction to: Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer

被引：0
|
作者：
Katherine A. Lyseng-Williamson
机构：
[1] Springer Nature,
来源：
Drugs | 2020年 / 80卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The author has alerted us to the following error.
引用
收藏
页码：2001 / 2001
相关论文
共 50 条
  • [21] Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer
    Mark Sanford
    Targeted Oncology, 2014, 9 : 85 - 94
  • [22] Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer
    Sanford, Mark
    TARGETED ONCOLOGY, 2014, 9 (01) : 85 - 94
  • [23] Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
    Oostra, Drew R.
    Macrae, Erin R.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 103 - 113
  • [24] TRASTUZUMAB EMTANSINE FOR THE TREATMENT OF HER2-POSITIVE METASTATIC BREAST CANCER
    Haddley, K.
    DRUGS OF TODAY, 2013, 49 (11) : 701 - 715
  • [25] FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer
    Wedam, Suparna
    Fashoyin-Aje, Lola
    Gao, Xin
    Bloomquist, Erik
    Tang, Shenghui
    Sridhara, Rajeshwari
    Goldberg, Kirsten B.
    King-Kallimanis, Bellinda L.
    Theoret, Marc R.
    Ibrahim, Amna
    Amiri-Kordestani, Laleh
    Pazdur, Richard
    Beaver, Julia A.
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4180 - 4185
  • [26] Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy
    Dhillon, Sohita
    DRUGS, 2014, 74 (06) : 675 - 686
  • [27] Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy
    Sohita Dhillon
    Drugs, 2014, 74 : 675 - 686
  • [28] Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer
    Haq, Bushra
    Geyer, Charles E.
    WOMENS HEALTH, 2009, 5 (02) : 135 - 147
  • [29] Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial
    Khattak, Monica N.
    Chichura, Anna M.
    Lang, Julie E.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1423 - 1427
  • [30] Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial
    Monica N. Khattak
    Anna M. Chichura
    Julie E. Lang
    Annals of Surgical Oncology, 2024, 31 : 1423 - 1427
12345